| Title: | Acute inflammatory response via neutrophil activation protects against the development of chronic pain |
| Journal: | Science Translational Medicine |
| Published: | 11 May 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35544595/ |
| DOI: | https://doi.org/10.1126/scitranslmed.abj9954 |
| URL: | https://www.science.org/doi/pdf/10.1126/scitranslmed.abj9954?download=true |
| Citations: | 151 (129 in last 2 years) as of 8 Aug 2024 |
Publication 7132
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
The transition from acute to chronic pain is critically important but not well understood. Here, we investigated the pathophysiological mechanisms underlying the transition from acute to chronic low back pain (LBP) and performed transcriptome-wide analysis in peripheral immune cells of 98 participants with acute LBP, followed for 3 months. Transcriptomic changes were compared between patients whose LBP was resolved at 3 months with those whose LBP persisted. We found thousands of dynamic transcriptional changes over 3 months in LBP participants with resolved pain but none in those with persistent pain. Transient neutrophil-driven up-regulation of inflammatory responses was protective against the transition to chronic pain. In mouse pain assays, early treatment with a steroid or nonsteroidal anti-inflammatory drug (NSAID) also led to prolonged pain despite being analgesic in the short term; such a prolongation was not observed with other analgesics. Depletion of neutrophils delayed resolution of pain in mice, whereas peripheral injection of neutrophils themselves, or S100A8/A9 proteins normally released by neutrophils, prevented the development of long-lasting pain induced by an anti-inflammatory drug. Analysis of pain trajectories of human subjects reporting acute back pain in the UK Biobank identified elevated risk of pain persistence for subjects taking NSAIDs. Thus, despite analgesic efficacy at early time points, the management of acute inflammation may be counterproductive for long-term outcomes of LBP sufferers.20 Authors
- Marc Parisien
- Lucas V Lima
- Concetta Dagostino
- Nehme El-Hachem
- Gillian L Drury
- Audrey V Grant
- Jonathan Huising
- Vivek Verma
- Carolina B Meloto
- Jaqueline R Silva
- Gabrielle G S Dutra
- Teodora Markova
- Hong Dang
- Philippe A Tessier
- Gary D Slade
- Andrea G Nackley
- Nader Ghasemlou
- Jeffrey S Mogil
- Massimo Allegri
- Luda Diatchenko
Enabling scientific discoveries that improve human health